Concepedia

I. Stavrakaki

IS

2

Publications

72

Citations

2

H-Index

2016

Active since

Affiliations

BBB Therapeutics (Netherlands)(Current)

I. Stavrakaki is an author at BBB Therapeutics (Netherlands) specializing in clinical trials, medicine, and pharmacotherapy.

Top concepts

MedicineClinical TrialsPharmacotherapyMultiple SclerosisHealthNeurologyDepressionImmunologySclerodermaPharmacology

Publications per year

2016–2018

2

Publications

2

Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse

Peter Joseph Jongen, I. Stavrakaki, Bernard Voet et al. · Journal of Neurology · 2016 · 43 citations · Full text

Daily Living, Multiple Sclerosis Patients, Neurological Disorder +13

Glutathione‐PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first‐in‐human study

Kawita M. S. Kanhai, Rob Zuiker, I. Stavrakaki et al. · British Journal of Clinical Pharmacology · 2018 · 29 citations · Full text

Immunology, Pharmacotherapy, Glucocorticoid +18

Rows per page

1–2 of 2